Dose-dependent augmentation effect of bromocriptine in a case with refractory depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 2, 2001, Pages 457-462

  Wada, T ^a   Kanno, M ^a   Aoshima, T ^a   Otani, K ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Augmentation effect; Bromocriptine; Dose dependency; Refractory depression

Indexed keywords

AMITRIPTYLINE; BROMOCRIPTINE; CLOMIPRAMINE; IMIPRAMINE; LIOTHYRONINE; LITHIUM; MAPROTILINE; MIANSERIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; TREATMENT FAILURE;

EID: 0035068424     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)80006-3     Document Type: Article

References (16)

1. Lithium augmentation in antidepressant-resistant patients: A quantitative analysis
2. Bromocriptine in depression
3. A trial of ECT is essential before a diagnosis of refractory depression is made
4. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine
5. A rating scale for depression
6. Monoamine neurotransmitter interactions and the prediction of antidepressant response
7. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression
8. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression
9. Current status of dopamine agonists in parkinson's disease management
10. Treatment-resistant depression: Definition and treatment approaches
11. Bromocriptine treatment of depressive disorders
12. Dopaminergic drugs and systems in refractory depression
13. Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms
14. A Comparative, Multicenter Trial Between Bromocriptine and Amitriptyline in the Treatment of Endogenous Depression
15. Bromocriptine and imipramine in endogenous depression